Mundi Pharma Pharmaceuticals Ltd
Millbank House, Arkle Road,
Sandyford, Dublin 18.
Tel: 01 206 3800
Fax: 01 294 5104
WWW : www.mundipharma.ie
Type of Business: Pharmaceutical.
Adizem SR Capsules, Adizem XL Capsules, BuTrans Matrix Patches, flutiform pMDI, flutiform k-haler, Herzuma Amps, Invokana Tablets, Levact concentrate for solution for infusion, MST Continus Tablets, MST Continus Suspension, Nyxoid nasal spray solution, OxyContin Tablets, OxyNorm Capsules, OxyNorm Liquid 1mg/ml, OxyNorm Liquid Concentrate 10mg/ml, OxyNorm Dispersa orodispersable Tablets, OxyNorm Solution for Injections, Palladone Caps/SR Caps, Palladone Caps/NR Caps, Phyllocontin Continus Tabs, Sevredol Tablets, Targin Tablets, Transtec Matrix Patches, Truxima concentrate for solution for infusion, Uniphyllin Continus Tabs, Vokanmet tablets.
Distribution: Via United Drug Distributors.
Mr Donagh O’Leary: Commercial Lead
Ms Kate Kelly: HR and Compliance Lead
Mr Tomás Morrissey: Head of Finance
Mr Michael Scott: Specialist Products Manager
Ms Helen Hanrahan: Interim Marketing Lead of Specialist Driven Primary Care
Medical Scientific Liaison:
Dr Serika Naicker: MSL
Primary Care Representatives:
Ms Josephine Finn, Mr Leonard Buckley, Mr Sean Henry, Ms Dympna Gaffney, Ms Nuala O’Connell, Mr Keith Donohue
Secondary Care Representatives:
Ms Aoife Smith, Ms Caroline O’Dwyer, Mr Alan O’Donnell
Adverse events should be reported to: HPRA Pharmacovigilance, Earlsfort Terrace, IRL – Dublin 2; Tel: +353 1 676 4971; Fax: +353 1 676 2517. Website: www.hpra.ie; Email@ firstname.lastname@example.org. Adverse events should also be reported to Mundipharma Pharmaceuticals Limited on email@example.com or by phone on 01 206 3800 (1800 991830 outside office hours).